Literature DB >> 20196724

The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure?

R A Claus1, C L Bockmeyer, M Sossdorf, W Lösche.   

Abstract

PURPOSE: This review investigates and highlights the activity of Willebrand factor (VWF) and its cleaving protease as biomarkers of the development of multiple organ dysfunction in infectious and noninfectious systemic inflammatory response syndrome. STATE OF THE ART: Ultra-large VWF (ULVWF) multimers activate platelets resulting in a prothrombotic situation. Systemic inflammation is associated with increased ULVWF plasma level and a decreased ADAMTS13 activity. The potential role of ADAMTS13 as a diagnostic and prognostic marker of disseminated intravascular coagulopathy is largely underestimated.
SUMMARY: VWF is an acute phase protein and its plasma level increases in systemic inflammation. When released from endothelial cells and platelets, the native multimeric glycoprotein is mostly present in the ultralarge form (ULVWF), which may have a major clinical significance under proinflammatory conditions. ULVWF-multimers may activate endothelial cells and platelets simultaneously. The multimers undergo limited proteolysis by a specific plasma metalloprotease known as ADAMTS13 (a disintegrin and metalloprotease with thrombospondin motif), thus, in healthy individuals only marginal amounts of circulating ULVWF are detectable. Severe hereditary or acquired ADAMTS13 deficiency causes thrombotic thrombocytopenic purpura (TTP), which contributes to prothrombotic coagulation abnormalities preceding organ dysfunction systemic inflammatory response syndrome (SIRS). In proinflammatory conditions, ADAMTS13 activity decreases due to various mechanisms, (i) down regulation on a transcriptional level, (ii) proteolytic degradation, and (iii) consumption due to the high substrate level. Marked dysbalance as found in patients with severe sepsis or septic shock results in substantial amounts of plasma ULVWF. This level of dysbalance is negatively correlated with platelet count and positively correlated with the severity of inflammation and the degree of organ failure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20196724     DOI: 10.2174/156652410790963367

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  31 in total

1.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

2.  Acute cholecystitis in thrombotic thrombocytopenic purpura.

Authors:  Avani Changela; Kinesh Changela; Hemangkumar Javaiya; Dipali Changela; Sarah Lee; Elizabeth Guevara
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-14       Impact factor: 0.900

3.  Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography.

Authors:  R Todd Stravitz; Ton Lisman; Velimir A Luketic; Richard K Sterling; Puneet Puri; Michael Fuchs; Ashraf Ibrahim; William M Lee; Arun J Sanyal
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

4.  Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.

Authors:  Michael L Ekaney; Clemens L Bockmeyer; Maik Sossdorf; Philipp A Reuken; Florian Conradi; Tobias Schuerholz; Markus F Blaess; Scott L Friedman; Wolfgang Lösche; Michael Bauer; Ralf A Claus
Journal:  Mol Med       Date:  2015-04-03       Impact factor: 6.354

5.  Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation.

Authors:  Yi Wang; Junmei Chen; Minhua Ling; José A López; Dominic W Chung; Xiaoyun Fu
Journal:  J Biol Chem       Date:  2014-11-24       Impact factor: 5.157

6.  A Review of Radiation-Induced Coagulopathy and New Findings to Support Potential Prevention Strategies and Treatments.

Authors:  Ann R Kennedy; Amit Maity; Jenine K Sanzari
Journal:  Radiat Res       Date:  2016-07-26       Impact factor: 2.841

7.  Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected].

Authors:  Yu Nobuoka; Hideo Wada; Shugo Mizuno; Masashi Kishiwada; Masanobu Usui; Hiroyuki Sakurai; Masami Tabata; Toshihiko Kobayashi; Tsutomu Nobori; Shinji Uemoto; Shuji Isaji
Journal:  Int J Hematol       Date:  2014-03-05       Impact factor: 2.490

8.  Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery.

Authors:  Kirsten A Kortekaas; Jan H N Lindeman; Marlies E J Reinders; Meindert Palmen; Robert J M Klautz; Philip G de Groot; Mark Roest
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-04

9.  Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.

Authors:  Stefano Lancellotti; Maria Basso; Vito Veca; Monica Sacco; Laura Riccardi; Maurizio Pompili; Raimondo De Cristofaro
Journal:  Intern Emerg Med       Date:  2016-05-24       Impact factor: 3.397

10.  The ABO Histo-Blood Group and AKI in Critically Ill Patients with Trauma or Sepsis.

Authors:  John P Reilly; Brian J Anderson; Nilam S Mangalmurti; Tam D Nguyen; Daniel N Holena; Qufei Wu; Ethan T Nguyen; Muredach P Reilly; Paul N Lanken; Jason D Christie; Nuala J Meyer; Michael G S Shashaty
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-04       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.